230
Participants
Start Date
December 14, 2022
Primary Completion Date
January 31, 2026
Study Completion Date
July 29, 2026
Oral Azacitidine
Specified dose on specified days
Placebo for Oral Azacitidine
Specified dose on specified days
Local Institution - 0178, Hksar
Local Institution - 0016, Buenos Aires
Local Institution - 0022, Buenos Aires
Local Institution - 0070, Pilar
Local Institution - 0018, Melbourne
Local Institution - 0003, Melbourne
Local Institution - 0004, Melbourne
Local Institution - 0006, Clayton
Local Institution - 0115, Aarhus
Local Institution - 0116, Aalborg
Local Institution - 0125, Chaïdári
Local Institution - 0132, East Syracuse
Local Institution - 0073, Pittsburgh
Local Institution - 0107, Granada
Local Institution - 0052, Rozzano
Local Institution - 0123, Fairfax
Local Institution - 0007, Hamburg
Local Institution - 0111, Madrid
Local Institution - 0112, Ourense
Local Institution - 0110, Oviedo
Local Institution - 0137, Miami
Local Institution - 0147, Tamarac
Local Institution - 0063, Pessac
Local Institution - 0108, Salamanca
Local Institution - 0024, Tours
Local Institution - 0101, Bologna
Local Institution - 0128, Düsseldorf
Local Institution - 0051, Junggu
Local Institution - 0109, Valencia
Local Institution - 0081, Duisburg
Local Institution - 0094, Angers
Local Institution - 0075, Florence
Local Institution - 0058, Hwasun Gun
Local Institution - 0056, Lille
Local Institution - 0028, Mutlangen
Local Institution - 0082, Paris
Local Institution - 0014, Houston
Local Institution - 0086, Houston
Local Institution - 0085, Villejuif
Local Institution - 0156, Wuhan
Local Institution - 0136, Kitakyushu-shi
Local Institution - 0039, ABB
Local Institution - 0050, Buenos Aires
Local Institution - 0008, Toronto
Local Institution - 0015, Toronto
Local Institution - 0090, Montreal
Local Institution - 0060, Hradec Králové
Local Institution - 0055, Leipzig
Local Institution - 0037, Dresden
Local Institution - 0129, Thessaloniki
Local Institution - 0127, Alexandroupoli
Local Institution - 0180, Shatin
Local Institution - 0061, Rome
Local Institution - 0154, Sapporo
Local Institution - 0153, Amagasaki
Local Institution - 0130, Sagamihara
Local Institution - 0135, Sendai
Local Institution - 0150, Shinagawa-ku
Local Institution - 0124, Osaka
Local Institution - 0097, Olsztyn
Local Institution - 0048, Seoul
Local Institution - 0036, Seoul
Local Institution - 0012, Seoul
Local Institution - 0118, Stockholm
Local Institution - 0119, Örebro
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY